|
PUBLICATIONS
Newton ILG, Woyke T, Auchtung TA, Dilly GF, Dutton RJ, Fisher MC, Fontanez KM, Lau E, Stewart FJ, Richardson PM, Barry KW, Detter JC, Wu D, Eisen JA, Cavanaugh CM. A window into hydrothermal vent endosymbioses: the Calyptogena magnifica chemoautotrophic symbiont genome. Manuscript in preparation.
Woyke T, Teeling H, Ivanova NN, Huntemann M, Richter M, Gloeckner FO, Boffelli D, Anderson IJ, Barry KW, Shapiro HJ, Szeto E, Kyrpides NC, Mussmann M, Amann R, Bergin C, Ruehland C, Rubin EM, Dubilier N. Symbiosis insights through metagenomic analysis of a microbial consortium (2006). Nature 443: 950-5.
Pettit RK, Woyke T, Pon S, Cichacz ZA, Pettit GR, Herald CL. In vitro and in vivo antifungal activities of the marine sponge constituent spongistatin (2005). Med Mycol 43: 453-63.
Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, McDonough WS, Sloan A, Coons SW, Berens ME. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets (2005). Neoplasia 7: 7-16.
Woyke T, Berens ME, Hoelzinger DB, Pettit GR, Winkelmann G, Pettit RK. Differential gene expression in auristatin PHE-treated Cryptococcus neoformans (2004). Antimicrob Agents Chemother 48: 561-7.
Woyke T, Roberson RW, Pettit GR, Winkelmann G, Pettit RK. Effect of auristatin PHE on microtubule integrity and nuclear localization in Cryptococcus neoformans (2002). Antimicrob Agents Chemother 46: 3802-8.
Woyke T, Pettit GR, Winkelmann G, Pettit RK. In vitro activities and postantifungal effects of the potent dolastatin 10 derivative auristatin PHE (2001). Antimicrob Agents Chemother 45: 3580-4.
COVER ILLUSTRATION
Woyke, T. and R.K. Pettit (2003). Microtubule skleton (anti-α-tubulin) and nuclei (DAPI) during the Cryptococcus neoformans cell cycle. J Med Microbiol. July 2003.
|
